Botulinum toxin therapy improves masseter spasticity in Amyotrophic Lateral Sclerosis.

Revue neurologique 2020 Vol.176(10) p. 870-873

Mongin M, Debs R, Le Forestier N, Lenglet T, Salachas F, Pradat PF, Amador MD, Bruneteau G, Degos B

관련 도메인

Abstract

Fifteen ALS patients, with troublesome symptoms linked to masseter spasticity, benefited from BoNT-A injections in each masseter. Based on the medical records of patients, the effect of the first injection was assessed one month later. We retrospectively collected information for 12 patients. Eight of them reported a beneficial effect after the injection for the following symptoms: trismus, tongue, lip and cheek biting, and jaw clonus. Five patients indicated that dental care was easier after injection. Our study showed that injections of BoNT-A unequivocally reduced masseter spasticity in ALS patients who subsequently enjoyed greater comfort in their daily living.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 1

MeSH Terms

Amyotrophic Lateral Sclerosis; Botulinum Toxins, Type A; Humans; Injections, Intramuscular; Muscle Spasticity; Retrospective Studies

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문